Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (24)

2023

  1. Seven Additional Patients with SOX17 Related Pulmonary Arterial Hypertension and Review of the Literature

    Genes, Vol. 14, Núm. 10

2022

  1. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  2. Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry

    International journal of molecular sciences, Vol. 23, Núm. 18

  3. Detection of azole resistance in Aspergillus fumigatus complex isolates using MALDI-TOF mass spectrometry

    Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 260-266

2021

  1. Azole and amphotericin B MIC values against aspergillus fumigatus: High agreement between spectrophotometric and visual readings using the EUCAST EDef 9.3.2 procedure

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 1

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  3. Chronic thromboembolic pulmonary hypertension in Spain: a decade of change

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 384-392

  4. Expanding the evidence of a semi-dominant inheritance in gdf2 associated with pulmonary arterial hypertension

    Cells, Vol. 10, Núm. 11

  5. Lack of relationship between genotype and virulence in Candida species

    Revista Iberoamericana de Micologia, Vol. 38, Núm. 1, pp. 9-11

  6. Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry

    Internal Medicine Journal, Vol. 51, Núm. 3, pp. 355-365

  7. Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry

    Respiratory Medicine, Vol. 178

2020

  1. Candidemia Candida albicans clusters have higher tendency to form biofilms than singleton genotypes†

    Medical mycology, Vol. 58, Núm. 7, pp. 887-895

  2. Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: Results from the PRACMA study

    BMC Pulmonary Medicine, Vol. 20, Núm. 1

  3. Genotyping Reveals High Clonal Diversity and Widespread Genotypes of Candida Causing Candidemia at Distant Geographical Areas

    Frontiers in Cellular and Infection Microbiology, Vol. 10

2019

  1. Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry

    International Journal of Cardiology, Vol. 275, pp. 158-164

2014

  1. Molecular identification and antifungal susceptibility of yeast isolates causing fungemia collected in a population-based study in Spain in 2010 and 2011

    Antimicrobial Agents and Chemotherapy, Vol. 58, Núm. 3, pp. 1529-1537

  2. Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?

    International Journal of Cardiology, Vol. 171, Núm. 1, pp. 15-23

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884

  2. Rejection after conversion to a proliferation signal inhibitor in chronic heart transplantation

    Clinical Transplantation, Vol. 27, Núm. 6

2012

  1. Steroid Withdrawal during 5 years following heart transplantation, and the relationship between steroid dosage at 1-year follow-up and complications during the next 2 years: Results from the restco study

    Transplantation Proceedings